Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The arterial blood pressure affects the ratio between filtration and reabsorption of fluids in the circulating blood volume and thereby the hematocrit. During induction of anesthesia blood pressure, hemoglobin level and hematocrit decreases. The aim of the study is to evaluate weather a maintained blood pressure with norepinephrine during anesthesia induction reduces the decrease in hematocrit.
24 patients scheduled for coronary artery bypass surgery will be included and randomized to receive either norepinephrine in the dose needed to maintain pre-anesthesia blood pressure or to a control group and receive norepinephrine only if mean arterial pressure decreases below 60 mmHg. Arterial blood gas will be analysed every ten minutes. Equal anesthesia in both groups will be monitored. No fluids will be infused. Noninvasive continuous hemoglobin measurement (SpHb) will be measured.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| control | No Intervention | Ordinary anesthesia, mean arterial pressure allowed to decrease to 60 mmHg. If it is lower the patients will receive a norepinephrine infusion in order to raise the mean arterial pressure to 60 mmHg. | |
| Maintained blood pressure | Active Comparator | Ordinary anaesthesia and maintained preanesthetic blood pressure by norepinephrine infusion |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Maintained blood pressure | Procedure | Norepinephrine therapy to maintain preanesthesia blood pressure |
|
| Measure | Description | Time Frame |
|---|---|---|
| The magnitude and dynamics of the decrease in hematocrit during anesthesia induction | 70 minutes from anesthesia induction |
| Measure | Description | Time Frame |
|---|---|---|
| Reduced hematocrit decrease by vasopressor infusion maintained blood pressure | To assess if the decrease in hematocrit can be reduced, by maintaining the blood pressure with vasopressor infusion | 70 minutes from anesthesia induction |
| Measure | Description | Time Frame |
|---|---|---|
| Accuracy of continuous non-invasive hemoglobin monitoring (SpHb) to invasive Hb levels | To evaluate if changes in invasive measured Hb levels, can be measured by continuous non-invasive hemoglobin monitoring (SpHb). | 70 minutes from anesthesia induction |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Tor Damén, MD | Contact | +46313427873 | tor.damen@vgregion.se | |
| Andreas Nygren, MD | Contact | +46313427444 | andreas.nygren@aniv.gu.se |
| Name | Affiliation | Role |
|---|---|---|
| Andreas Nygren, MD PHD | Sweden: Sahlgrenska University hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sahlgrenska University Hospital | Recruiting | Gothenburg | Sweden | 41345 | Sweden |
| Type | Date | Date Unknown |
|---|---|---|
| Release | May 31, 2016 | |
| Reset | Jul 8, 2016 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| May 31, 2016 | Jul 8, 2016 |
| ID | Term |
|---|---|
| D009638 | Norepinephrine |
| D014662 | Vasoconstrictor Agents |
| ID | Term |
|---|---|
| D004983 | Ethanolamines |
| D000605 | Amino Alcohols |
| D000438 | Alcohols |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Norepinephrine | Drug | Norepinephrine therapy to maintain preanesthesia blood pressure |
|
|
| D000588 |
| Amines |
| D015306 | Biogenic Monoamines |
| D001679 | Biogenic Amines |
| D002395 | Catecholamines |
| D002396 | Catechols |
| D010636 | Phenols |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D002317 | Cardiovascular Agents |
| D045506 | Therapeutic Uses |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |